TY  - JOUR

T1  - The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): A living meta-analysis.

JO  - Journal of Clinical Oncology

UR  - http://dx.doi.org/10.1200/jco.2023.41.16_suppl.5088

PY  - 2023/06/01

AU  - Naqvi SAA

AU  - Riaz IB

AU  - He H

AU  - Imran M

AU  - Orme J

AU  - Childs DS

AU  - Ravi P

AU  - Hussain SA

AU  - Singh P

AU  - Bryce AH

ED  - 

DO  - DOI: 10.1200/jco.2023.41.16_suppl.5088

PB  - American Society of Clinical Oncology (ASCO)

VL  - 41

IS  - 16_suppl

SP  - 5088

EP  - 5088

Y2  - 2024/12/21

ER  -